INH14
INH14 is a novel small molecule inhibitor that selectively targets IKKα and IKKβ with IC50 values of 8.97 μM and 3.59 μM, respectively. It is a valuable research tool for studying the IKK-dependent TLR inflammatory signaling pathway in both cellular and animal models of inflammation and immune response.
Product Specifications
CAS Number
200134-22-1
Product Name Alternative
I kappa B kinase, Inhibitor, IkB, IkB/IKK, IKK, INH14, INH-14, INH 14, inhibit, IκB, IκB kinase, IKKα, IKKβ
Field of Research
Signal Transduction
Purity
95.41% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (16.65 mM) ; DMSO:100 mg/mL (416.15 mM)
Smiles
CCc1ccc (NC (=O) Nc2ccccc2) cc1
Molecular Formula
C15H16N2O
Molecular Weight
240.3
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
128835-ML405 100 µL
KIR3DL1 (Killer Cell Immunoglobulin-like Receptor 3DL1, CD158 Antigen-like Family Member E, HLA-BW4-specific Inhibitory NK Cell Receptor, MHC Class I NK Cell Receptor, Natural Killer-associated Transcript 3, NKAT-3, p70 Natural Killer Cell Receptor Clones CL-2/CL-11, p70 NK Receptor CL-2/CL-11, CD158e, CD158E, NKAT3, NKB1) (MaxLight 405) discontinued
Sign In for Pricing
View Details 
126989-ML405 100 µL
FRS2 (Fibroblast Growth Factor Receptor Substrate 2, FGFR Substrate 2, FGFR-signaling Adaptor SNT, Suc1-associated Neurotrophic Factor Target 1, SNT-1) (MaxLight 405) discontinued
Sign In for Pricing
View Details